Lateral Capital Management
VC Fund
Sarasota, United States
Lateral Capital Management is a VC fund in Sarasota focused on Medical and Health Care. Lateral Capital is an early-stage investment company that invests in technology companies to bring new products and services to the market.It invests in technology from health care to industrial products; from specialty B2B software to cancer vaccines. Before investing, the company makes sure that the company that they will be investing have acompleted product or service with compelling benefits, proprietary technology with issued or filed patents, logical strategic buyers who will want to buy the company, and business models which lead to cash flow breakeven while the company waits for a buyer.It was founded in 2003 in Sarasota, Florida.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 0%
- Fund size:
- $3.2M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Lateral Capital Management invests in
Stages Lateral Capital Management invests in
Countries Lateral Capital Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $777k–$4.9M
- Series A
- $2M–$15M
Investment Focus
Industry
- Medical 2 (20%)
- Health Care 2 (20%)
- Manufacturing 2 (20%)
- Medical Device 2 (20%)
- Drones 1 (10%)
Stage
- Seed 4 (40%)
- Series A 3 (30%)
- Funding Round 2 (20%)
Country
- United States 6 (60%)
- Nigeria 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
John Lilly
Managing Member
|
Managing Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ateios
|
Ateios is enabling a new generation of thin and flexible electronics with our ultra-thin, conformable, and customizable batteries. The company's current focus is zinc-oxide batteries, that achieve 2-5x higher energy density compared to coin cells. Ateios’ novel manufacturing process allows customizable batteries that can be shaped around theneeds of the product.The company was founded in 2018. | $7.3M / Series A / Mar 23, 2026 | |
Natilus
|
Natilus is a large scale drone manufacturing company. The company specializes in the manufacturing of Boeing 747 sized drones which provides inter-continental cargo delivery services and helps in reducing air freight costs. Natilus was founded by LZ Zhang, Anatoly Starikov and Aleksey Matyushev in 2016.First flight of their 2200 lbs / 30 ftdrone is scheduled for Summer 2018. At the end of 2018, Natilus completed a flight test of their 2200 lbs prototype.The first production vehicle scheduled for 2020 customer delivery underwent wind tunnel testing in April, 2019. Natilus currently holds an aircraft order book rumored to be in excess of $1B+. | Dec 16, 2022 | |
Mesh++
|
Mesh++ is a solar-powered routers developer. Mesh++ uses mobile processing power to deliver a high-speed WiFi connection to outdoors and public places. | $4.9M / Oct 21, 2021 | |
|
Mesh++
|
Mesh++ is a solar-powered routers developer. Mesh++ uses mobile processing power to deliver a high-speed WiFi connection to outdoors and public places. | $4.9M / Seed / Oct 21, 2021 | |
Mono
|
Mono creates API financial platform that helps companies in collecting and managing bank transfer payments. The company was founded in 2020 by Abdulhamid Hassan and Prakhar Singh and is headquartered in Lagos, Nigeria. | $15M / Series A / Oct 11, 2021 | |
Pathology Watch
|
Pathology Watch delivers an intuitive and easy-to-implement digital pathology solution for dermatologists. They work with clinical dermatology practices to digitize the pathology workflow, which is helping to improve the quality of patient care, reduce costs, and open up new potential streams of revenue for clinics and hospitals. They also deliveran intuitive and easy-to-implement digital pathology solution that includes access to top-tier Dermatopathologists.It was founded in 2017 and is based in Salt Lake City, Utah. | $2M / Series A / Nov 01, 2020 | |
Vaporox
|
Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT), a patented and FDA-510(k)-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs), as well as amputations, burns, frostbite, gangrene, pressure ulcers (bed sores), and skin grafts.After establishingVHT as the preferred treatment for DFUs, Vaporox intends to look at extending its technology to treat other types of skin wounds and maladies, or licensing VHT to other medical device companies. | $777K / Seed / Apr 01, 2020 | |
|
Mesh++
|
Mesh++ is a solar-powered routers developer. Mesh++ uses mobile processing power to deliver a high-speed WiFi connection to outdoors and public places. | $4.9M / Seed / Oct 22, 2019 | |
Agribody Technologies, Inc.
|
Agribody Technologies is a agricultural biotechnology company with patented technology that pinpoints and knocks down the gene that causes quick decay in perishable crops, resulting in 3X - 4X longer shelf life, more tolerance to stress, and up to 40% higher yields. CRISPR genome editing is the technical breakthrough enabling our precise novelplant trait development at low cost and high scalability, providing solutions for agricultural crop loss and food waste. We license and co-develop our technology. | $1.6M / Seed / Dec 25, 2017 | |
|
Natilus
|
Natilus is a large scale drone manufacturing company. The company specializes in the manufacturing of Boeing 747 sized drones which provides inter-continental cargo delivery services and helps in reducing air freight costs. Natilus was founded by LZ Zhang, Anatoly Starikov and Aleksey Matyushev in 2016.First flight of their 2200 lbs / 30 ftdrone is scheduled for Summer 2018. At the end of 2018, Natilus completed a flight test of their 2200 lbs prototype.The first production vehicle scheduled for 2020 customer delivery underwent wind tunnel testing in April, 2019. Natilus currently holds an aircraft order book rumored to be in excess of $1B+. | Seed / Nov 13, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lateral Capital Management invest in?
Lateral Capital Management invests primarily in Medical, Health Care and Manufacturing startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Lateral Capital Management's check size?
Lateral Capital Management typically joins rounds of $777k–$4.9M at Seed and $2M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lateral Capital Management participates in.
How do I contact Lateral Capital Management?
Public channels for Lateral Capital Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lateral Capital Management?
The team at Lateral Capital Management includes John Lilly (Managing Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
